Anil K. Suri

New Delhi, DL 110067, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources.

Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources.

Journal: Vaccines

Published: October 27, 2023

Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate molecule for immunotherapy in cervical cancer.

Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate molecule for immunotherapy in cervical cancer.

Journal: Cancer cell international

Published: November 12, 2020

Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells in vitro and in vivo.

Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells in vitro and in vivo.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: April 29, 2020

Erratum: Heat shock protein 70-2 (HSP70-2) a novel cancer testis antigen that promotes growth of ovarian cancer.

Erratum: Heat shock protein 70-2 (HSP70-2) a novel cancer testis antigen that promotes growth of ovarian cancer.

Journal: American journal of cancer research

Published: April 29, 2020

Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.

Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: May 11, 2018

Role of A-Kinase anchor protein (AKAP4) in growth and survival of ovarian cancer cells.

Role of A-Kinase anchor protein (AKAP4) in growth and survival of ovarian cancer cells.

Journal: Oncotarget

Published: December 29, 2016

Heat shock protein 70-2 (HSP70-2) a novel cancer testis antigen that promotes growth of ovarian cancer.

Heat shock protein 70-2 (HSP70-2) a novel cancer testis antigen that promotes growth of ovarian cancer.

Journal: American journal of cancer research

Published: October 01, 2016

Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer.

Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 19, 2016

Spindle Cell Variant of Embryonal Rhabdomyosarcoma: A Rare Entity with Diagnostic Challenges.

Spindle Cell Variant of Embryonal Rhabdomyosarcoma: A Rare Entity with Diagnostic Challenges.

Journal: Journal of clinical and diagnostic research : JCDR

Published: March 02, 2016

Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.

Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: January 28, 2016

A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.

A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 01, 2015

Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.

Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.

Journal: BMC cancer

Published: August 31, 2015

Showing 1-12 of 29

Last Updated: 09/26/2026